Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis

By G. Cantù. 2021

Subfields: Oncology, Otorhinolaryngology

Citations in the corpus

• Immunohistochemical Analysis of Potential Therapeutic Targets PRAME, FOLR1, and CLDN18.2 in Salivary Gland Carcinomas (2026, unknown): “Standard treatment modalities—surgery, radiotherapy, and chemotherapy—frequently yield limited success, emphasizing the need for novel, targeted therapeutic strategies [6–8].”